{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,27]],"date-time":"2026-03-27T23:51:32Z","timestamp":1774655492270,"version":"3.50.1"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,2,25]],"date-time":"2026-02-25T00:00:00Z","timestamp":1771977600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,3,27]],"date-time":"2026-03-27T00:00:00Z","timestamp":1774569600000},"content-version":"vor","delay-in-days":30,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Hunan innovative province construction project","award":["2019SK2211"],"award-info":[{"award-number":["2019SK2211"]}]},{"name":"Hunan innovative province construction project","award":["2019SK2211"],"award-info":[{"award-number":["2019SK2211"]}]},{"name":"Hunan innovative province construction project","award":["2019SK2211"],"award-info":[{"award-number":["2019SK2211"]}]},{"DOI":"10.13039\/501100019091","name":"Key research and development project of Hunan Province","doi-asserted-by":"crossref","award":["2020SK2089"],"award-info":[{"award-number":["2020SK2089"]}],"id":[{"id":"10.13039\/501100019091","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100019091","name":"Key research and development project of Hunan Province","doi-asserted-by":"crossref","award":["2020SK2089"],"award-info":[{"award-number":["2020SK2089"]}],"id":[{"id":"10.13039\/501100019091","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100019091","name":"Key research and development project of Hunan Province","doi-asserted-by":"crossref","award":["2020SK2089"],"award-info":[{"award-number":["2020SK2089"]}],"id":[{"id":"10.13039\/501100019091","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100004761","name":"The Natural Science Foundation of Hunan province","doi-asserted-by":"crossref","award":["2020JJ4833, 2019SK2211, and XY040019"],"award-info":[{"award-number":["2020JJ4833, 2019SK2211, and XY040019"]}],"id":[{"id":"10.13039\/501100004761","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100004761","name":"The Natural Science Foundation of Hunan province","doi-asserted-by":"crossref","award":["2020JJ4833, 2019SK2211, and XY040019"],"award-info":[{"award-number":["2020JJ4833, 2019SK2211, and XY040019"]}],"id":[{"id":"10.13039\/501100004761","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100004761","name":"The Natural Science Foundation of Hunan province","doi-asserted-by":"crossref","award":["2020JJ4833, 2019SK2211, and XY040019"],"award-info":[{"award-number":["2020JJ4833, 2019SK2211, and XY040019"]}],"id":[{"id":"10.13039\/501100004761","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Hunan Province Key Field R&D Program","award":["2020SK2097"],"award-info":[{"award-number":["2020SK2097"]}]},{"name":"Hunan Province Key Field R&D Program","award":["2020SK2097"],"award-info":[{"award-number":["2020SK2097"]}]},{"name":"Hunan Province Key Field R&D Program","award":["2020SK2097"],"award-info":[{"award-number":["2020SK2097"]}]},{"name":"Horizontal Project","award":["KY080269, KY080262, XY080323, and XY080324"],"award-info":[{"award-number":["KY080269, KY080262, XY080323, and XY080324"]}]},{"name":"Horizontal Project","award":["KY080269, KY080262, XY080323, and XY080324"],"award-info":[{"award-number":["KY080269, KY080262, XY080323, and XY080324"]}]},{"name":"Horizontal Project","award":["KY080269, KY080262, XY080323, and XY080324"],"award-info":[{"award-number":["KY080269, KY080262, XY080323, and XY080324"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-026-40860-5","type":"journal-article","created":{"date-parts":[[2026,2,25]],"date-time":"2026-02-25T18:45:50Z","timestamp":1772045150000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Association of antibiotic type and timing with sepsis mortality using target trial emulation"],"prefix":"10.1038","volume":"16","author":[{"given":"Jiayang","family":"Li","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mingyi","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qingnan","family":"He","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,2,25]]},"reference":[{"issue":"Suppl 1","key":"40860_CR1","first-page":"67","volume":"61","author":"I Srzi\u0107","year":"2022","unstructured":"Srzi\u0107, I., Nesek Adam, V. & Tunji\u0107 Pejak, D. Sepsis definition: What\u2019s new in the treatment guidelines. Acta Clin. Croat. 61 (Suppl 1), 67\u201372 (2022).","journal-title":"Acta Clin. Croat"},{"key":"40860_CR2","first-page":"56","volume":"9","author":"D Liu","year":"2022","unstructured":"Liu, D. et al. Sepsis-induced immunosuppression: Mechanisms, diagnosis and current treatment options. Mil Med. Res. 9, 56 (2022).","journal-title":"Mil Med. Res."},{"key":"40860_CR3","doi-asserted-by":"publisher","first-page":"1478","DOI":"10.1001\/jama.2020.2717","volume":"323","author":"JL Vincent","year":"2020","unstructured":"Vincent, J. L. et al. Prevalence and outcomes of infection among patients in intensive care units in 2017. JAMA 323, 1478\u20131487 (2020).","journal-title":"JAMA"},{"key":"40860_CR4","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1001\/jama.2014.5804","volume":"312","author":"V Liu","year":"2014","unstructured":"Liu, V. et al. Hospital deaths in patients with sepsis from 2 independent cohorts. JAMA 312, 90\u201392 (2014).","journal-title":"JAMA"},{"key":"40860_CR5","doi-asserted-by":"publisher","first-page":"1559","DOI":"10.1164\/rccm.201701-0241OC","volume":"196","author":"J Hou","year":"2017","unstructured":"Hou, J. et al. S1PR3 Signaling drives bacterial killing and is required for survival in bacterial sepsis. Am. J. Respir Crit. Care Med. 196, 1559\u20131570 (2017).","journal-title":"Am. J. Respir Crit. Care Med."},{"key":"40860_CR6","doi-asserted-by":"publisher","unstructured":"Vincent, J. L. Current sepsis therapeutics. EBioMedicine. (2022). https:\/\/doi.org\/10.1016\/j.ebiom.2022.104318","DOI":"10.1016\/j.ebiom.2022.104318"},{"key":"40860_CR7","doi-asserted-by":"publisher","first-page":"1138","DOI":"10.1097\/CCM.0000000000006274","volume":"52","author":"M Klompas","year":"2024","unstructured":"Klompas, M. & Rhee, C. Victories and opportunities in the surviving sepsis campaign\u2019s antibiotic timing guidance. Crit. Care Med. 52, 1138\u20131141 (2024).","journal-title":"Crit. Care Med."},{"key":"40860_CR8","doi-asserted-by":"publisher","first-page":"762","DOI":"10.1001\/jama.2016.0288","volume":"315","author":"CW Seymour","year":"2016","unstructured":"Seymour, C. W. et al. Assessment of clinical criteria for sepsis: For the third international consensus definitions for sepsis and septic shock (Sepsis-3). JAMA 315, 762\u2013774 (2016).","journal-title":"JAMA"},{"key":"40860_CR9","doi-asserted-by":"publisher","first-page":"1631","DOI":"10.1093\/cid\/cix997","volume":"66","author":"Infectious Diseases Society of America (IDSA) POSITION STATEMENT","year":"2018","unstructured":"Infectious Diseases Society of America (IDSA) POSITION STATEMENT. Why IDSA did not endorse the surviving sepsis campaign guidelines. Clin. Infect. Dis. 66, 1631\u20131635 (2018).","journal-title":"Clin. Infect. Dis."},{"issue":"11","key":"40860_CR10","doi-asserted-by":"publisher","first-page":"e1063","DOI":"10.1097\/CCM.0000000000005337","volume":"49","author":"L Evans","year":"2021","unstructured":"Evans, L. et al. Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock 2021. Crit. Care Med. 49 (11), e1063\u2013e1143 (2021).","journal-title":"Crit. Care Med."},{"key":"40860_CR11","doi-asserted-by":"publisher","DOI":"10.1016\/j.drup.2023.101012","author":"C de la Fuente-Nunez","year":"2023","unstructured":"de la Fuente-Nunez, C., Cesaro, A. & Hancock, R. E. W. Antibiotic failure: Beyond antimicrobial resistance. Drug Resist. Updat. https:\/\/doi.org\/10.1016\/j.drup.2023.101012 (2023).","journal-title":"Drug Resist. Updat"},{"key":"40860_CR12","doi-asserted-by":"publisher","first-page":"4046","DOI":"10.1128\/AAC.00678-12","volume":"56","author":"AE Barnhill","year":"2012","unstructured":"Barnhill, A. E., Brewer, M. T. & Carlson, S. A. Adverse effects of antimicrobials via predictable or idiosyncratic inhibition of host mitochondrial components. Antimicrob. Agents Chemother. 56, 4046\u20134051 (2012).","journal-title":"Antimicrob. Agents Chemother."},{"key":"40860_CR13","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1001\/jama.2022.21383","volume":"328","author":"MA Hern\u00e1n","year":"2022","unstructured":"Hern\u00e1n, M. A., Wang, W. & Leaf, D. E. Target trial emulation: A framework for causal inference from observational data. JAMA 328, 46\u20132447 (2022).","journal-title":"JAMA"},{"key":"40860_CR14","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1001\/jama.2023.18591","volume":"330","author":"SYC Tong","year":"2023","unstructured":"Tong, S. Y. C., Venkatesh, B. & McCreary, E. K. Acute kidney injury with empirical antibiotics for sepsis. JAMA 330, 531\u20131533 (2023).","journal-title":"JAMA"},{"key":"40860_CR15","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1016\/S1473-3099(17)30615-1","volume":"18","author":"KZ Vardakas","year":"2018","unstructured":"Vardakas, K. Z., Voulgaris, G. L., Maliaros, A., Samonis, G. & Falagas, M. E. Prolonged versus short-term intravenous infusion of antipseudomonal \u03b2-lactams for patients with sepsis: A systematic review and meta-analysis of randomised trials. Lancet Infect. Dis. 18, 108\u2013120 (2018).","journal-title":"Lancet Infect. Dis."},{"key":"40860_CR16","doi-asserted-by":"crossref","unstructured":"Veiga, R. P. & Paiva, J. A. Pharmacokinetics-pharmacodynamics issues relevant for the clinical use of beta-lactam antibiotics in critically ill patients. Crit Care 22,233 (2018).","DOI":"10.1186\/s13054-018-2155-1"},{"key":"40860_CR17","first-page":"594","volume":"43","author":"Hanrahan","year":"2015","unstructured":"Hanrahan et al. Factors associated with vancomycin nephrotoxicity in the critically ill. Anaesth. Intensive Care. 43, 594\u2013599 (2015).","journal-title":"Intensive Care"},{"key":"40860_CR18","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1139\/cjm-2019-0309","volume":"66","author":"E M\u00fchlberg","year":"2020","unstructured":"M\u00fchlberg, E. et al. Renaissance of vancomycin: Approaches for breaking antibiotic resistance in multidrug-resistant bacteria. Can. J. Microbiol. 66, 11\u201316 (2020).","journal-title":"Can. J. Microbiol."},{"key":"40860_CR19","doi-asserted-by":"publisher","first-page":"1760","DOI":"10.1093\/cid\/cit560","volume":"57","author":"KW McConeghy","year":"2013","unstructured":"McConeghy, K. W., Bleasdale, S. C. & Rodvold, K. A. The empirical combination of vancomycin and a \u03b2-lactam for staphylococcal bacteremia. Clin. Infect. Dis. 57, 1760\u20131765 (2013).","journal-title":"Clin. Infect. Dis."},{"key":"40860_CR20","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1097\/CCM.0000000000004776","volume":"49","author":"EP Plata-Menchaca","year":"2021","unstructured":"Plata-Menchaca, E. P. & Ferrer, R. Procalcitonin Is useful for antibiotic deescalation in sepsis. Crit. Care Med. 49, 693\u2013696 (2021).","journal-title":"Crit. Care Med."},{"key":"40860_CR21","doi-asserted-by":"publisher","first-page":"856","DOI":"10.1164\/rccm.201609-1848OC","volume":"196","author":"VX Liu","year":"2017","unstructured":"Liu, V. X. et al. The timing of early antibiotics and hospital mortality in sepsis. Am. J. Respir Crit. Care Med. 196, 856\u2013863 (2017).","journal-title":"Am. J. Respir Crit. Care Med."},{"key":"40860_CR22","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1186\/s13054-021-03787-z","volume":"25","author":"MH Kollef","year":"2021","unstructured":"Kollef, M. H. et al. Timing of antibiotic therapy in the ICU. Crit. Care. 25, 360 (2021).","journal-title":"Crit. Care"},{"key":"40860_CR23","doi-asserted-by":"publisher","first-page":"1749","DOI":"10.1097\/CCM.0000000000000330","volume":"42","author":"R Ferrer","year":"2014","unstructured":"Ferrer, R. et al. Empiric antibiotic treatment reduces mortality in severe sepsis and septic shock from the first hour: Results from a guideline-based performance improvement program. Crit. Care Med. 42, 1749\u20131755 (2014).","journal-title":"Crit. Care Med."},{"key":"40860_CR24","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1016\/j.chest.2021.06.029","volume":"161","author":"R Bisarya","year":"2022","unstructured":"Bisarya, R. et al. Antibiotic timing and progression to septic shock among patients in the ED with suspected infection. Chest 161, 112\u2013120 (2022).","journal-title":"Chest"},{"key":"40860_CR25","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/S2213-2600(17)30469-1","volume":"6","author":"N Alam","year":"2018","unstructured":"Alam, N. et al. Prehospital antibiotics in the ambulance for sepsis: A multicentre, open label, randomised trial. Lancet Respir Med. 6, 40\u201350 (2018).","journal-title":"Lancet Respir Med."},{"key":"40860_CR26","doi-asserted-by":"publisher","first-page":"1907","DOI":"10.1097\/CCM.0000000000001142","volume":"43","author":"SA Sterling","year":"2015","unstructured":"Sterling, S. A., Miller, W. R., Pryor, J., Puskarich, M. A. & Jones, A. E. The impact of timing of antibiotics on outcomes in severe sepsis and septic shock: A systematic review and meta-analysis. Crit. Care Med. 43, 1907\u20131915 (2015).","journal-title":"Crit. Care Med."},{"key":"40860_CR27","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1186\/s13054-021-03883-0","volume":"26","author":"Y Im","year":"2022","unstructured":"Im, Y. et al. Time-to-antibiotics and clinical outcomes in patients with sepsis and septic shock: A prospective nationwide multicenter cohort study. Crit. Care. 26, 19 (2022).","journal-title":"Crit. Care"},{"key":"40860_CR28","doi-asserted-by":"publisher","unstructured":"Matthews, A. A., Danaei, G., Islam, N. & Kurth, T. Target trial emulation: Applying principles of randomised trials to observational studies. BMJ. (2022). https:\/\/doi.org\/10.1136\/bmj-2022-071108 .","DOI":"10.1136\/bmj-2022-071108"},{"key":"40860_CR29","doi-asserted-by":"publisher","first-page":"1369","DOI":"10.1056\/NEJMclde1815472","volume":"380","author":"AX Chen","year":"2019","unstructured":"Chen, A. X., Simpson, S. Q. & Pallin, D. J. Sepsis guidelines. N Engl. J. Med. 380, 1369\u20131371 (2019).","journal-title":"N Engl. J. Med."},{"key":"40860_CR30","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijantimicag.2023.106732","author":"S Einav","year":"2023","unstructured":"Einav, S., Leone, M. & Martin-Loeches, I. Sepsis and antibiotics: When should we deploy a parachute? Int. J. Antimicrob. Agents. https:\/\/doi.org\/10.1016\/j.ijantimicag.2023.106732 (2023).","journal-title":"Int. J. Antimicrob. Agents"},{"key":"40860_CR31","doi-asserted-by":"publisher","first-page":"800","DOI":"10.1164\/rccm.201703-0621ED","volume":"196","author":"M Singer","year":"2017","unstructured":"Singer, M. Antibiotics for Sepsis: Does Each Hour Really Count, or Is It Incestuous Amplification? Am. J. Respir Crit. Care Med. 196, 800\u2013802 (2017).","journal-title":"Am. J. Respir Crit. Care Med."},{"key":"40860_CR32","doi-asserted-by":"publisher","first-page":"1958","DOI":"10.1007\/s00134-016-4577-z","volume":"42","author":"A Perner","year":"2016","unstructured":"Perner, A. et al. Sepsis: Frontiers in diagnosis, resuscitation and antibiotic therapy. Intensive Care Med. 42, 1958\u20131969 (2016).","journal-title":"Intensive Care Med."},{"key":"40860_CR33","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/j.jinf.2021.03.003","volume":"82","author":"SA Asner","year":"2021","unstructured":"Asner, S. A., Desgranges, F., Schrijver, I. T. & Calandra, T. Impact of the timeliness of antibiotic therapy on the outcome of patients with sepsis and septic shock. J. Infect. 82, 125\u2013134 (2021).","journal-title":"J. Infect."},{"key":"40860_CR34","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2020.2899","author":"C Rhee","year":"2021","unstructured":"Rhee, C. et al. Prevalence of antibiotic-resistant pathogens in culture-proven sepsis and outcomes associated with inadequate and broad-spectrum empiric antibiotic use. JAMA Netw. Open. https:\/\/doi.org\/10.1001\/jamanetworkopen.2020.2899 (2021).","journal-title":"JAMA Netw. Open."},{"key":"40860_CR35","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1016\/j.cmi.2018.05.016","volume":"25","author":"CS Scheer","year":"2019","unstructured":"Scheer, C. S. et al. Impact of antibiotic administration on blood culture positivity at the beginning of sepsis: A prospective clinical cohort study. Clin. Microbiol. Infect. 25, 326\u2013331 (2019).","journal-title":"Clin. Microbiol. Infect."},{"key":"40860_CR36","doi-asserted-by":"publisher","DOI":"10.1097\/CCM.0000000000005090","author":"CN Shappell","year":"2021","unstructured":"Shappell, C. N., Klompas, M., Ochoa, A. & Rhee, C. Likelihood of bacterial infection in patients treated with broad-spectrum IV antibiotics in the emergency department. Crit. Care Med. https:\/\/doi.org\/10.1097\/CCM.0000000000005090 (2021).","journal-title":"Crit. Care Med."},{"key":"40860_CR37","doi-asserted-by":"publisher","first-page":"1133","DOI":"10.1007\/s00134-022-06769-z","volume":"48","author":"RA Lukaszewski","year":"2022","unstructured":"Lukaszewski, R. A. et al. Presymptomatic diagnosis of postoperative infection and sepsis using gene expression signatures. Intensive Care Med. 48, 1133\u20131143 (2022).","journal-title":"Intensive Care Med."},{"key":"40860_CR38","doi-asserted-by":"publisher","first-page":"1974","DOI":"10.1097\/CCM.0000000000005357","volume":"49","author":"L Evans","year":"2021","unstructured":"Evans, L. et al. Executive summary: Surviving Sepsis campaign: International guidelines for the management of sepsis and septic shock 2021. Crit. Care Med. 49, 1974\u20131982 (2021).","journal-title":"Crit. Care Med."},{"key":"40860_CR39","doi-asserted-by":"publisher","first-page":"893","DOI":"10.1038\/s41586-024-07725-1","volume":"632","author":"TH Kim","year":"2024","unstructured":"Kim, T. H. et al. Blood culture-free ultra-rapid antimicrobial susceptibility testing. Nature 632, 893\u2013902 (2024).","journal-title":"Nature"},{"key":"40860_CR40","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciae445","author":"SP Taylor","year":"2024","unstructured":"Taylor, S. P. et al. Development of an electronic clinical surveillance measure for unnecessary rapid antibiotic administration in suspected sepsis. Clin. Infect. Dis. https:\/\/doi.org\/10.1093\/cid\/ciae445 (2024).","journal-title":"Clin. Infect. Dis."},{"key":"40860_CR41","doi-asserted-by":"publisher","first-page":"957","DOI":"10.1007\/s00134-024-07428-1","volume":"50","author":"T Zimmermann","year":"2024","unstructured":"Zimmermann, T., Brealey, D. & Singer, M. Diagnosing sepsis: Where we\u2019re at and where we\u2019re going. Intensive Care Med. 50, 957\u2013959 (2024).","journal-title":"Intensive Care Med."},{"key":"40860_CR42","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1016\/j.idc.2022.08.001","volume":"36","author":"TR Pak","year":"2022","unstructured":"Pak, T. R., Rhee, C. & Klompas, M. Timing and spectrum of antibiotic treatment for suspected sepsis and septic shock: Why so controversial? Infect. Dis. Clin. North. Am. 36, 719\u2013733 (2022).","journal-title":"Infect. Dis. Clin. North. Am."},{"key":"40860_CR43","doi-asserted-by":"publisher","first-page":"1578","DOI":"10.1111\/cts.13030","volume":"14","author":"I Taneja","year":"2021","unstructured":"Taneja, I. et al. Diagnostic and prognostic capabilities of a biomarker and EMR-based machine learning algorithm for sepsis. Clin. Transl Sci. 14, 1578\u20131589 (2021).","journal-title":"Clin. Transl Sci."},{"key":"40860_CR44","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1016\/S1473-3099(20)30477-1","volume":"21","author":"SS Kadri","year":"2021","unstructured":"Kadri, S. S. et al. Inappropriate empirical antibiotic therapy for bloodstream infections based on discordant in-vitro susceptibilities: A retrospective cohort analysis of prevalence, predictors, and mortality risk in US hospitals. Lancet Infect. Dis. 21, 241\u2013251 (2021).","journal-title":"Lancet Infect. Dis."},{"issue":"8","key":"40860_CR45","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1001\/jama.2016.0287","volume":"315","author":"M Singer","year":"2016","unstructured":"Singer, M. et al. The third international consensus definitions for sepsis and septic shock (Sepsis-3). JAMA 315 (8), 801\u2013810 (2016).","journal-title":"JAMA"},{"key":"40860_CR46","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1186\/s13054-023-04587-3","volume":"27","author":"W Hu","year":"2023","unstructured":"Hu, W. et al. Identification of indications for albumin administration in septic patients with liver cirrhosis. Crit. Care. 27, 300 (2023).","journal-title":"Crit. Care"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-40860-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-40860-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-40860-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,27]],"date-time":"2026-03-27T23:01:57Z","timestamp":1774652517000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-40860-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,25]]},"references-count":46,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["40860"],"URL":"https:\/\/doi.org\/10.1038\/s41598-026-40860-5","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,25]]},"assertion":[{"value":"20 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 February 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 February 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study complied with the declaration of Helsinki. The author Jiayang Li has completed the Collaborative Institutional Training Program (CITP) exam (certification number: 13808420), and since the retrospective cohort study using de-identified public data; IRB approval waived.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Since MIMIC-IV includes only anonymized information, patient consent to participate was waived at the local institution. Informed consent is not required for the secondary use of this de-identified database.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"10447"}}